Saturday, August 1, 2020
It is 2020 and we still have to remind the health care decision makers that data need to be collected, analyzed, and reported by race, ethnicity, and gender. The reason behind this push to have meaningful inclusion of diverse population is that it is good science; and, to not do so may have dangerous consequences. This is especially true for clinical trials as they are meant to provide information that is useful about anyone who will use it or take it. Here is our OpEd piece on COVID-19 vaccine clinical trials that appeared in The Hill.
As COVID-19 began to change our way of life I knew that this would be a hard time for most people and that many people would need support. I wrote the first edition in 2011 and because of how the science has advanced and how our expectations have changed what started as an update ended up being 90% new plus 92 endnotes.
Life has changed and what is needed is a combination of science, clinical insights, and the lessons learned from many others. There is much that we can do on our own to make our lives better and when we cannot do it alone...there are many options for treatment.
The book is available at Amazon and at your local bookstores.